Physician profile
Howard E Borger
NPI 1003879925
$1,025.18
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $125 · 2021: $132 · 2022: $62.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $368.92 | 2019-2021 | |
| Alcon Vision LLC | $242.76 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $138.47 | 2019 | |
| Aerie Pharmaceuticals, INC. | $52.10 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $48.70 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $39.80 | 2019 | |
| Kala Pharmaceuticals, INC. | $34.91 | 2019-2020 | |
| Ocular Therapeutix, INC. | $24.83 | 2019 | |
| Baxter Healthcare | $24.25 | 2022 | |
| Abbvie INC. | $22.43 | 2022 | |
| Oyster Point Pharma, INC. | $15.64 | 2022 | |
| Omeros Corporation | $12.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Borger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.